Macrofocal multiple myeloma in the era of novel agents in China
Background: Macrofocal multiple myeloma (MFMM) is characterized by clonal plasma cells comprising less than 20% of the bone marrow, multiple lytic bone lesions, and the absence of anemia, renal insufficiency, and hypercalcemia. This subtype of multiple myeloma (MM) has a relatively low incidence. Pr...
Saved in:
Main Authors: | Xuelin Dou, Ruixia Liu, Yang Liu, Nan Peng, Lei Wen, Daoxing Deng, Leqing Cao, Qian Li, Liru Wang, Fengrong Wang, Xiaodong Mo, Jin Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Therapeutic Advances in Hematology |
Online Access: | https://doi.org/10.1177/20406207251314696 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thromboprophylaxis in multiple myeloma
by: Laurent Frenzel
Published: (2025-01-01) -
Multiple Myeloma of the Orbit
by: Mona Hassan, et al.
Published: (2012-01-01) -
Targeting BCMA in multiple myeloma: designs, challenges, and future directions
by: Yi Hu, et al.
Published: (2025-02-01) -
Synchronous multiple myeloma and lung adenocarcinoma: A clinical series
by: Fang Ye, et al.
Published: (2024-04-01) -
The Evolution of Prognostic Factors in Multiple Myeloma
by: Amr Hanbali, et al.
Published: (2017-01-01)